DIRS.INFO The most relevant business & tech news

☆ More CEOs are deciding the stress, pressure, and loneliness are just not worth the money
▼ + stars: | 2024-04-30 | by ( Theron Mohamed | ) www.businessinsider.com time to read: +4 min

download the appSign up to get the inside scoop on today’s biggest stories in markets, tech, and business — delivered daily. Pressure, stress, and lonelinessHead honchos have been calling out the difficulties of their jobs for years. Tesla and SpaceX CEO Elon Musk has bemoaned that running a company is "really not that fun" and "just awful" at times. "The depths of loneliness I experienced as a CEO are difficult to put into words," he posted on X in January. The combination of immense pressure, stress, loneliness, and lack of work-life balance that often comes with being a CEO may well explain why few people last long in the role.

Persons: —, HSBC's Noel Quinn, Bob Bakish, Dr Martens, Kenny Wilson, Andrew Challenger, HSBC's Quinn, Elon Musk, Musk, Grzegorz Wajda, Brian Chesky, Warren Buffett, Berkshire Hathaway, Buffett Organizations: Service, Paramount, Business, SpaceX, Berkshire, he's

☆ Private equity double-dips are a tasty faux pas
▼ + stars: | 2023-12-04 | by ( Aimee Donnellan | ) www.reuters.com time to read: +3 min

Private equity groups are trying something similar in the capital markets: successfully listing a company, then coming back for a second bite by buying it back once its stock craters. Take Synlab (SYAB.DE), listed at the height of a Covid-19 boom in testing by investment group Cinven. European companies listed by private equity groups since 2020 are trading, on average, at a 22% discount to their IPO price, according to data from Dealogic and Breakingviews calculations. The message from such deals, however, is that it’s better to buy a private equity-owned company after it has listed. Follow @aimeedonnellan on XCONTEXT NEWSPrivate equity firm Cinven on Sept. 29 offered 10 euros a share to take Covid test maker Synlab private.

Persons: Russell Boyce, Synlab, Cinven’s, Cinven, Sweden’s, Dr Martens, Elliott, Neil Unmack, Oliver Taslic Organizations: REUTERS, Reuters, Revenue, Thomson Locations: London, Britain, Cinven, France, Dealogic, Permira, Synlab

☆ Dr Martens shares slide 27% as the British bootmaker warns on profits
▼ + stars: | 2023-11-30 | by ( ) edition.cnn.com time to read: +2 min

Shares in Dr Martens dived more than 27% Thursday after the company issued its fourth profit warning in 12 months, blaming lackluster demand from US wholesalers for its clunky boots and a slower start to the autumn-winter season. Shares in the British company, which went public in 2021, hit a record low of 79.10 pence ($1) Thursday after the firm also scrapped its revenue guidance for the 2025 fiscal year. For the first half of the year, the company said its wholesale revenue dropped 17% to $199.4 million ($251.9 million). The company said it had offered small discounts on seasonal colors but would not mark down prices on its flagship black shoes. Analysts forecast a range of $223.7 million—$240 million ($282.6 million—$303 million), according to numbers compiled by the company.

Persons: Martens, we’ve, Kenny Wilson, Dr Martens, Wilson Organizations: Reuters Locations: British, United States, United Kingdom, Europe, Asia, Pacific

☆ Birkenstock's IPO is set to boost another footwear stock by 65%, analyst says
▼ + stars: | 2023-10-13 | by ( Ganesh Rao | ) www.cnbc.com time to read: +3 min

Birkenstock 's recent initial public offering (IPO) is expected to help boost shares of British footwear brand Dr. Martens , according to Investec analysts. The analysts pointed out that Birkenstock's sales last year were slightly higher than Dr. Martens' projected sales this year. However, the German company sells over twice the volume of footwear as Dr. Martens, which has a higher average selling price. DOCS-GB YTD line Similarities and differences Birkenstock's business model and brand ethos have many similarities to Dr. Martens, according to the analysts. RBC said it has a "Sector Perform" rating, equivalent to "hold" at other investment banks, on Dr. Martens.

Persons: Birkenstock, Martens, Kate Calvert, Ben Hunt, Dr Martens Organizations: New York Stock Exchange, RBC Capital Markets, RBC Locations: London, British, Germany, U.S, Europe, Asia, Pacific

A pair of shoes is pictured in a window of a Birkenstock footwear store in Berlin, Germany, January 21, 2021. Birkenstock is the latest high-profile listing to put investor focus on the initial public offering (IPO) market, which is gradually reopening after two relatively quiet years and a burst of activity in September. Due to recent price hikes, worldwide footwear sales are expected to rise just 2.9% over 2022, according to market research firm Euromonitor International. AllBirds (BIRD.O), Dr Martens (DOCS.L), and On Running (ONON.N) have all seen their market value fall since their IPOs in 2021. "When you look at the trend of other shoe companies that have IPO-ed, it doesn't give a great outlook for Birkenstock," Valechha said.

Persons: Fabrizio Bensch, Birkenstock, Kellogg, Mamta, Cheviot, Valechha, Johann Adam Birkenstock, Barbie, Margot Robbie, Jessica Ramirez, Jane Hali, Siobhan Gehin, Roland Berger, Thomas Hayes, sneaker, Dr Martens, Allbirds, Alexandre Arnault, LVMH, Bernard Arnault, Matt Oguz, Iris, L, Ananya Mariam Rajesh, Helen Reid, Emma, Victoria Farr, Echo Wang, Abigail Summerville, Deepa Babington Organizations: REUTERS, LVMH, New York Stock Exchange, Euromonitor, Associates, Dick's Sporting, Reuters, Partners, Norges Bank Investment Management, Thomson Locations: Berlin, Germany, New York, London, Neustadt, United States, U.S, Cannes, Silicon Valley

☆ U.S. consumer outlook dims as upscale retailers, discounters slash forecasts
▼ + stars: | 2023-06-01 | by ( Aishwarya Venugopal | ) www.reuters.com time to read: +3 min

Broadly, U.S. consumer spending trends showed resilience in the face of high inflation, but big-ticket purchases suffered. Upscale retailer Macy's said the U.S. consumer pulled back more than anticipated and slashed its annual sales and profit forecasts for the year. Macy's and lingerie brand Victoria's Secret & Co (VSCO.N) are resorting to more discounts to clear out excess inventory. "Our business in North America became increasingly more challenging," Victoria's Secret CEO Martin Waters said during a post earnings call on Thursday. The pinch from slowing consumer spending was not just limited to high-end retailers.

Persons: Macy's, Hogan, Martin Waters, they're, Nordstrom, Peter Nordstrom, Dr Martens, Arun Sundaram, Aishwarya Venugopal, Savyata Mishra, Shinjini Organizations: U.S, Goods, Riley, Nordstrom Inc, Discount, CFRA Research, Thomson Locations: U.S, North America, United States, Bengaluru

☆ Miners, energy firms drag FTSE 100 lower; Dr Martens hits record low
▼ + stars: | 2023-01-19 | by ( Johann M Cherian | ) www.reuters.com time to read: +2 min

SummarySummary Companies FTSE 100 sheds 0.6%, FTSE 250 off 1.0%Deliveroo achieves breakeven in second halfBoohoo's Christmas revenue drops 11%Dr Martens sinks to FTSE 250 bottom on annual profit warningJan 19 (Reuters) - UK's commodity-heavy FTSE 100 fell on Thursday, with energy firms and material stocks dragging the benchmark index lower, while shares of bootmaker Dr Martens slumped to a record low after its annual profit warning. The FTSE 100 (.FTSE) slid 0.6%, while the domestically-oriented FTSE 250 (.FTMC) shed 1.0%. Energy heavyweights Shell (SHEL.L) and BP (BP.L) fell below 1.7%, while industrial miners (.FTNMX551020) shed 1.8% as crude and copper prices declined after disappointing U.S. economic data and on worries about a hawkish Federal Reserve. Dr Martens (DOCS.L) sank 23.6%, after it warned of a lower annual profit and revenue due to operational issues at its new U.S. distribution centre. Reporting by Johann M Cherian in Bengaluru; Editing by Savio D'Souza and Shailesh KuberOur Standards: The Thomson Reuters Trust Principles.

☆ UK's Dr Martens warns on profit after U.S distribution centre issues
▼ + stars: | 2023-01-19 | by ( ) www.reuters.com time to read: 1 min

Jan 19 (Reuters) - Dr Martens Plc (DOCS.L) on Thursday warned on annual profit and revenue after the British bootmaker faced operational issues at its new distribution centre in the United States. The company said it now expected a revenue growth of 11%-13% on an actually currency basis for the year ending March, lower than the previous forecast of a jump in high-teens. Dr Martens said its third quarter was weaker than expected as operational issues at its new Los Angeles distribution centre led to lost wholesale revenue and additional costs, reducing its 2023 core profit by 16 million pounds to 25 million pounds ($19.7 million-$30.8 million). ($1 = 0.8108 pounds)Reporting by Aby Jose Koilparambil in Bengaluru; Editing by Subhranshu SahuOur Standards: The Thomson Reuters Trust Principles.

The pan-European STOXX 600 (.STOXX) was down 0.8% at 0929 GMT, and on track to snap a six-day winning streak. Energy stocks (.SXEP) fell 1.9%, tracking weakness in crude prices, after U.S. economic data stoked fears of recession in the world's largest economy. "Economic data remains noisy, making it hard to say for certain that the recent encouraging economic trends will continue," said Mark Haefele, chief investment officer at UBS Global Wealth Management. Dutch central bank chief Klaas Knot added to the chorus, saying markets may be underestimating planned rate hikes by the European Central Bank and investors should take more seriously its forecast to raise rates in multiples of 50 basis points. Investors are focussed on minutes from last month's European Central Bank meeting due later in the day, as well as an appearance from ECB President Christine Lagarde at the World Economic Forum in Davos.

Search resuls for: "Dr Martens"

9 mentions found